| Association of survival and immune-related biomarkers with immunotherapy in patients with non–small cell lung cancer: A meta-analysis and individual patient–level analysis Y Yu, D Zeng, Q Ou, S Liu, A Li, Y Chen, D Lin, Q Gao, H Zhou, W Liao, ... JAMA network open 2 (7), e196879-e196879, 2019 | 224 | 2019 |
| Development and validation of a preoperative magnetic resonance imaging radiomics–based signature to predict axillary lymph node metastasis and disease-free survival in … Y Yu, Y Tan, C Xie, Q Hu, J Ouyang, Y Chen, Y Gu, A Li, N Lu, Z He, ... JAMA network open 3 (12), e2028086-e2028086, 2020 | 205 | 2020 |
| Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in … Y Yu, Z He, J Ouyang, Y Tan, Y Chen, Y Gu, L Mao, W Ren, J Wang, L Lin, ... EBioMedicine 69, 2021 | 166 | 2021 |
| Comparison of face-touching behaviors before and during the coronavirus disease 2019 pandemic YJ Chen, G Qin, J Chen, JL Xu, DY Feng, XY Wu, X Li JAMA network open 3 (7), e2016924-e2016924, 2020 | 124 | 2020 |
| Association of long noncoding RNA biomarkers with clinical immune subtype and prediction of immunotherapy response in patients with cancer Y Yu, W Zhang, A Li, Y Chen, Q Ou, Z He, Y Zhang, R Liu, H Yao, E Song JAMA Network open 3 (4), e202149-e202149, 2020 | 82 | 2020 |
| Impact of fundamental diseases on patients with COVID-19 Y Chen, T Li, Y Ye, Y Chen, J Pan Disaster medicine and public health preparedness 14 (6), 776-781, 2020 | 37 | 2020 |
| Prognostic and immunological role of CD36: A pan-cancer analysis YJ Chen, WX Liao, SZ Huang, YF Yu, JY Wen, J Chen, DG Lin, XY Wu, ... Journal of Cancer 12 (16), 4762, 2021 | 32 | 2021 |
| Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) HY Zhou, SP Zheng, AL Li, QL Gao, QY Ou, YJ Chen, ST Wu, DG Lin, ... EClinicalMedicine 24, 2020 | 24 | 2020 |
| Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma Q Ou, Y Yu, A Li, J Chen, T Yu, X Xu, X Xie, Y Chen, D Lin, Q Zeng, ... Annals of Translational Medicine 8 (5), 2020 | 21 | 2020 |
| Clinical evidence for locoregional surgery of the primary tumor in patients with de novo stage IV breast cancer Y Yu, H Hong, Y Wang, T Fu, Y Chen, J Zhao, P Chen, R Cai, Y Tan, Z He, ... Annals of Surgical Oncology, 1-12, 2021 | 17 | 2021 |
| Association of immune checkpoint inhibitor therapy with survival in patients with cancers with MUC16 variants Y Yu, D Lin, A Li, Y Chen, Q Ou, H Hu, H Yao JAMA Network Open 3 (6), e205837-e205837, 2020 | 16 | 2020 |
| Neutrophil-to-apolipoprotein A1 ratio predicted overall survival in hepatocellular carcinoma receiving transarterial chemoembolization J Chen, YJ Chen, N Jiang, JL Xu, ZM Liang, MJ Bai, YF Xing, Z Liu, ... The oncologist 26 (8), e1434-e1444, 2021 | 13 | 2021 |
| Mandatory mask-wearing and hand hygiene Associated with decreased infectious diseases among patients undergoing regular hemodialysis: a historical-control study JJ Qin, YF Xing, JH Ren, YJ Chen, YF Gan, YQ Jiang, J Chen, X Li Frontiers in Public Health 9, 678738, 2021 | 8 | 2021 |
| Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation Z He, A Li, D Lin, Y Gu, Y Chen, Q Ou, L Li, H Yao, Y Yu Clinical and Translational Medicine 10 (6), 2020 | 8 | 2020 |
| Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers A Li, Y Chen, W Zhang, H Zhong, Q Ou, Y Gu, J Xia, D Lin, T Fu, R Liu, ... Clinical and Translational Medicine 10 (2), 2020 | 7 | 2020 |
| Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score … W Ren, Y Yu, H Hong, Y Wang, Q Gao, Y Chen, P Chen, J Zhao, Q Ou, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2022 | 5 | 2022 |
| Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm … H Zhou, L Lin, T Qin, W Ren, Y Tan, Q Yang, H Xu, X Xie, Y Chen, S Liu, ... Journal of Thoracic Disease 13 (11), 6468, 2021 | 5 | 2021 |
| Corticosteroids combined with doublet or single-agent immunosuppressive therapy for active proliferative lupus nephritis B Liu, Q Ou, Y Tang, S Fu, P Liang, Y Yu, Z Xu, Y Chen, A Xu Clinical Rheumatology 38, 2519-2528, 2019 | 5 | 2019 |
| Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized … Y Yu, Y Chen, A Li, Q Ou, Q Li, Y Gu, D Lin, W Zhang, J Wang, X Tang, ... Clinical and Translational Medicine 10 (2), 2020 | 3 | 2020 |
| Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion X Li, J Chen, YJ Chen, YD Qiao, LY Zhao, N Jiang, XY Wu, YF Xing Communications Biology 4 (1), 252, 2021 | 2 | 2021 |
Yunfang YuSun Yat-sen Memorial Hospital, Sun Yat-sen UniversityVerified email at mail.sysu.edu.cn
